SARS‐CoV‐2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California

The SARS‐CoV‐2 (COVID‐19) pandemic continues to affect many lives globally. Patients with cancer undergoing potentially immunosuppressive therapies appear to be at particular risk for the disease and its complications. Here, we describe the experience of patients with cancer within Kaiser Permanente...

Descripción completa

Detalles Bibliográficos
Autores principales: Anantharaman, Archana, Dusendang, Jennifer R., Schmittdiel, Julie A., Harzstark, Andrea L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753632/
https://www.ncbi.nlm.nih.gov/pubmed/33210439
http://dx.doi.org/10.1002/onco.13602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753632/
https://www.ncbi.nlm.nih.gov/pubmed/33210439
http://dx.doi.org/10.1002/onco.13602

Ejemplares similares